Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Delfi Diagnostics Inc.
Headquarters: Baltimore, MD, United States of America
Website: https://delfidiagnostics.com/...
Year Founded: 2018
Status: Private
BioCentury | Dec 3, 2024
Management Tracks
Bob Valamehr to succeed CEO Scott Wolchko at Fate
Plus: Amoolya Singh named CTO of Delfi and updates from Torl, OSE and George Clinical
BioCentury | Oct 31, 2024
Discovery & Translation
Science Spotlight: Macrophage-fibroblast cross-talk in heart failure
BioCentury’s roundup of translational innovations also includes synthetic gene regulators, three longevity genes and more
BioCentury | Aug 27, 2024
Management Tracks
Patel joins Sana as EVP, CSO
Plus: Ian Clements named CFO of Marea, new role at BII for Soni and more
BioCentury | Aug 3, 2024
Deals
Biotechs find problem-solving in academia, and mostly outside the big hubs
Academia-biotech deals span innovative assets to tissue bank resources to enabling technologies
BioCentury | Jan 23, 2024
Politics, Policy & Law
How Arnold Ventures paved the road to the IRA
And what the biopharma industry’s most effective critic wants to do next
BioCentury | Jan 6, 2024
Management Tracks
Management moves abound on eve of JPM, including new chairs for Sobi, Corteria
Plus: Zaderej to retire as AxoGen CEO and updates from AxoGen, Delfi, Illumina, Evozyne, Kiyatec, Sosei, Twist, Novocure, Be Bio, Novo Holdings, Bioluminescence and more
BioCentury | Jul 11, 2023
Finance
Menlo Ventures continues scaling focus on tech-enabled bio
Menlo is looking to invest in generative AI for drug design and problem-solvers for gene editing — and to grow its healthcare team
BioCentury | Feb 25, 2023
Management Tracks
Delfi promotes Buechel to president and COO
Plus: changes at Precision and updates for the TB Alliance and FDA
BioCentury | Jul 18, 2022
Emerging Company Profile
Delfi: Making early cancer detection tests more accessible
Diagnostic company aims for early 2023 early cancer detection test launch with $225M B round
BioCentury | Mar 18, 2022
Management Tracks
Investment banking vet Lang becomes CFO at Aerie
Plus Mission names Essig chair, and updates from enGene, NRx,
Items per page:
1 - 10 of 17